MBB PUBLIC MARKETS I LLC - CRINETICS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
MBB PUBLIC MARKETS I LLC ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$258,797
+12.2%
8,702
-32.0%
0.02%
+33.3%
Q2 2023$230,692
+22.8%
12,802
+9.4%
0.01%
+20.0%
Q1 2023$187,93411,7020.01%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,375,169$76,819,0007.66%
RA Capital Management 1,875,209$42,680,0001.84%
Perceptive Advisors 2,587,953$58,901,0001.66%
EMORY UNIVERSITY 97,035$2,209,0001.55%
New Leaf Venture Partners, L.L.C. 167,700$3,817,0001.05%
Orbimed Advisors 1,914,282$43,569,0000.67%
Opaleye Management Inc. 73,000$1,661,0000.46%
Novo Holdings A/S 135,009$3,073,0000.46%
Virtus ETF Advisers LLC 7,934$181,0000.38%
Eventide Asset Management 384,000$8,740,0000.30%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders